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Background: Research has shown that obese individuals have cognitive deficiencies in executive function, leading
to poor planning and impulse control, and decision-making difficulties. An intervention that could help reduce
these deficits and in turn help weight loss maintenance is Cognitive Remediation Therapy for Obesity (CRT-O). We
aim to examine the efficacy of manualised CRT-O, which is intended to improve executive function, enhance reflective
practice and help weight loss maintenance.
Methods/Design: A randomised controlled trial (registered with the Australian New Zealand Clinical Trials Registry) will
be conducted. First, 90 obese adults (body mass index >30 kg/m2) in the community will receive three weekly sessions
of a group Behaviour Weight Loss Treatment (BWLT), and then will be randomised either to receive CRT-O or to enter
a no-treatment control group. CRT-O training will comprise twice-weekly sessions of 45 minutes over a 4 to 6 week
period, for a total of eight sessions. Measurement points will be at baseline, post CRT-O (or 4 to 6 weeks after BWLT for
the no-treatment control), 3 months post treatment and 1 year post treatment. The primary outcome will be executive
function and secondary outcome measures will include participants’ body mass index, hip to waist ratio, eating
behaviours and quality of life.
Discussion: This is the first study of its kind to examine the efficacy of Cognitive Remediation Therapy for
obese adults through a randomised controlled trial.
Trial Registration: Australian New Zealand Clinical Trials Registry number: 12613000537752. Date of
registration: 14 May 2013.
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Approximately 1 billion adults are currently overweight
(body mass index (BMI) 25 to 29.9 kg/m2) and a further
475 million are obese (BMI >30 kg/m2) [1]. Ranking sec-
ond only to smoking as a preventable cause of death,
obesity contributes to over 300,000 deaths per year [2].
Obesity is also associated with a wide range of medical
and psychological sequelae, eating disorder behaviours
such as binge eating and subsequent impaired health-
related quality of life (HRQoL) [3-5]. Although 5% to
10% weight loss is associated with clear health benefits,* Correspondence: P.Hay@uws.edu.au
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unless otherwise stated.the prevention of weight regain has remained a chal-
lenge. Even with the help of professionals and extended
behavioural treatments, weight regain typically occurs
when professional contact ends [6]. By 3 to 5 years post-
treatment, about 85% of patients have regained weight
or even exceeded their pre-treatment weight [7].
Empirical research has found obesity to be associated
with cognitive impairment, especially in executive func-
tion, irrespective of the presence of binge eating [8] and
independent of co-morbid medical conditions such as
diabetes, hypertension and cancer, which are themselves
associated with adverse cognitive effects [9,10]. Execu-
tive function encompasses a range of cognitive processes
facilitating initiation, planning, regulation, inhibition, se-
quencing and achievement of complex goal-orientedLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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deficits is found across the age span, in children, adoles-
cents, older adults, middle-aged adults and young adults
[12-14]. A review [15] found that the evidence is highly
consistent, with 22 out of 24 studies showing a negative
association between obesity and cognition, especially in
executive function. For example, inhibitory control, an
aspect of executive function, involves the suppression of
actions that are contextually inappropriate and interfere
with behavioural goals. Studies of obese adults in the com-
munity have found executive deficits to be positively asso-
ciated with disinhibited eating and greater food cravings
[16]. Furthermore, obese individuals have been found to
demonstrate cognitive impulsivity, an autonomic readi-
ness to make quick decisions, which prevents successful
inhibition of a prepotent behavioural response. It has been
shown that impulsive subjects have marked limitations for
learning suitable associations between reward and punish-
ment [17,18] and as a result they are more influenced by
immediate rewards than by future consequence [18].
Hence, executive deficits have been shown to impair the
capacity for impulse regulation, including control over the
impulse to eat excessively [19]. Furthermore, evidence in-
dicates a positive association between a higher BMI and
decision-making impairments [20]. Findings from a study
on the decision-making profiles of obese adult females
using the Iowa Gambling Task showed a preference for
high immediate reward, despite higher future losses in
terms of both physical and psychological outcomes [18].
Studies have also shown that obese individuals perform
similarly on the Iowa Gambling Task as those with an-
orexia nervosa, for example, see [21], and as patients with
orbitofrontal dysfunction [22], and worse than those who
are substance dependent [23]. While executive function
deficits have been shown to be similar in anorexia nervosa
and obesity, obese individuals show worse performance in
the inhibition response measured by the Stroop test com-
pared to individuals with anorexia nervosa or healthy con-
trols [24].
The mechanism by which obesity is associated with
cognitive function is, however, unclear at present [8].
Smith and colleagues [15] suggested a bidirectional rela-
tionship between obesity and executive function, where
obesity impairs executive function via biological mecha-
nisms, such as inflammatory markers or glucose abnormal-
ities, and impaired executive function impacts on obesity
by causing an inability to regulate food intake, plan ahead,
inhibit responses or act impulsively. There is some evi-
dence for this bidirectional association. One longitudinal
study showed that poor executive function at age four pre-
dicted a high BMI at age six [14]. It is possible, based on
the evidence presented above, that cognitive deficiencies
may contribute to increased adiposity by exacerbating
weight gain or regain after weight loss, and targeting thesedeficits in the obese has the potential to improve partici-
pants’ response to therapy. This led to the development of
a novel treatment for weight disorders, namely Cognitive
Remediation Therapy for Obesity (CRT-O) [15,25].
CRT-O is a manualised treatment derived from Cogni-
tive Remediation Therapy (CRT), which is used to treat
people with addiction, feeding or eating disorders. In trials
of people with a substance-use disorder, computer-assisted
CRT has been shown to reduce individuals’ need for im-
mediate reward and improve their decision-making [26].
Experimental studies have shown that practicing inhibi-
tory control, an aspect of executive function, reduces the
consumption of high-calorie foods [12,27,28]. Specifically,
studies have shown that improving inhibition of behaviour
towards high-calorie items, via a computerised go/no-go
task, reduced the consumption of palatable foods across a
1-day period [12,28]. Similarly, manualised Cognitive Re-
mediation Therapy for Anorexia Nervosa (CRT-AN) has
been shown to be associated with cognitive improvements
in addition to improvements in eating-disorder-related
quality of life at the end of treatment and eating-disorder
psychopathology at a 6-month follow-up [29]. Further-
more, there were low dropout rates and high levels of ac-
ceptability among both patients and therapists [30].
Like CRT-AN, CRT-O is designed to provide individuals
with the tools to think differently about their cognitive
style and how they address food. However, in CRT-O the
intent is to help maintain weight loss and prevent further
weight gain by linking the thinking style to food intake
and exercise behaviours. CRT-O is a brief eight-session in-
dividual therapy where simple cognitive tasks and exer-
cises that encourage reflective learning and insight into a
participant’s own thinking process are administered to-
gether with intra-session experimentation. The rationale
being that this will improve various aspects of executive
function, including cognitive flexibility, central coherence
(attention to detail) and problem-solving and will in turn
improve participants’ ability to follow the guidelines of a
behavioural weight-loss programme. Supporting this are
promising results from a small trial (n =44) by Verbeken
et al. [12], testing executive function training with games
in children. In this study, moderate to large effect sizes
(standardised mean differences between 0.5 and 0.6) were
found in executive function outcomes, such as improve-
ments in a behaviour rating inventory of executive func-
tion and in a working memory task that favoured training.
However, there were smaller effects for a task assessing re-
sponse inhibition. To our knowledge the efficacy of this
approach has not yet been investigated in adults.
We have designed the present randomised controlled trial
(RCT) to test the efficacy of manualised individual face-
to-face CRT-O as developed by Smith and colleagues [25].
The primary outcome in this superiority trial is improve-
ment in executive function demonstrated at end of
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follow-up. Secondary outcomes are participants’ BMI, hip
to waist ratio, eating behaviours and quality of life. Since
studies on anorexia nervosa have found an improvement
in quality of life, we wish to examine whether quality of
life improves after CRT-O. In this RCT, all participants
receive standard care for weight loss, namely group-
based Behaviour Weight Loss Treatment (BWLT), and
are then randomised to a CRT-O group or a no-treatment
control group. CRT-O targets executive function deficits
and changes in thinking style, whereas BWLT targets
health literacy and weight-loss strategies including psycho-
education, weight monitoring, dietary advice and exercise
planning. Perceived barriers to weight management are
discussed and challenged.
The primary hypothesis is that, compared to those
who receive BWLT only, participants who receive BWLT
plus CRT-O will demonstrate improved executive func-
tion post treatment, which is maintained at the 3-month
and 1-year follow-ups. The secondary hypotheses are
that that executive function changes will predict changes
in weight, and compared to those who receive BWLT
only, participants who receive BWLT plus CRT-O will
have improved (i) weight loss (assessed by BMI and hip
to waist ratio), (ii) HRQoL and (iii) dietary habits (in-
cluding reduced binge eating) at post treatment and
maintained at the 3-month and 1-year follow-ups.
Methods/Design
Participants
First, 90 obese individuals are recruited via direct adver-
tisement to the community in Sydney, Australia. Inclu-
sion criteria are: BMI ≥30 kg/m2, age 18 to 55 years,
current weight under 180 kg, ability to provide informed
consent and having completed 10 years of education in
English. Participants who are depressed, have a binge
eating disorder, are currently on psychotropic medication,
have hypertension (medicated or not medicated), type 2
diabetes, or high cholesterol are eligible. Participants are
excluded if they have a history of psychosis, head injury,
neurological disorder including degenerative or inflamma-
tory conditions or stroke, attention deficit hyperactivity
disorder, epilepsy, developmental or intellectual disability;
are unable to complete the testing (e.g. due to hearing, vi-
sion or language impediment); are on regular sedative or
stimulant medication; and/or report regular substance use
or abuse (for alcohol, more than two standard drinks five
times a week). Individuals are also be excluded if they
regularly use sedatives, hypnotics, antipsychotics, or
anti-cholinergic or cholinergic medication. The sample
size of 45 per group has been determined based on power
estimates using Cohen’s tables for an estimated effect
size of 0.6, power of 0.8, one-tailed test, P <0.05 and
attrition of 20%. Although there are no previousstudies of adults with obesity, these levels are commensur-
ate with those achieved by Verbeken et al. [12].
Procedure
Recruitment was via advertisements placed on social
media sites, university and community centre notice
boards and via media interviews with journalists from
metropolitan and community newspapers. The initial
screen was by phone to establish potential eligibility.
This was followed by a face-to-face psychological and
neuropsychological assessment. All 90 participants then
receive group-based BWLT that will run once a week for
3 weeks, each session lasting 90 minutes. At the comple-
tion of the third and final session, participants are randomly
allocated to CRT-O or no treatment. Randomisation and al-
location concealment are conducted using an external
computer-based program [31]. The RCT is registered with
the Australian New Zealand Registry of Clinical Trials (trial
id ACTRN12613000537752) (Figure 1).
Assessment
After providing information on demographic and med-
ical factors, including their weight, height, waist and
hip circumferences, participants undergo a battery of
neuropsychological and psychological tests. All assessment
measures will be administered at baseline, after 7 to 9
weeks (3 weeks of BWLT and 4 to 6 weeks of either CRT
or no treatment), and at the 3-month and 1-year post-
CRT follow-ups. At the follow-ups, participants will also
be asked whether they received any further treatment for
their obesity. We will control for this in the final analyses.
Neuropsychological assessment
The six neuropsychological tests employed are selected be-
cause they cover different aspects of executive functioning
and are commonly used in clinical and research settings.
The tests are administered individually to all subjects by a
trained clinical psychologist or neuropsychologist.
1. The Wisconsin Card Sorting Test (WCST) 64: The
computerised version of WCST [32-34] will be used.
In this test, subjects are instructed to categorise a
series of cards according to one of three stimulus
features (colour, shape or number of illustrations on
them), without this principle being revealed to the
subject. After each association, the only feedback
given is whether a match is correct or incorrect, the
idea being that subjects should infer how to
categorise based on the feedback they receive. This
test measures categorisation, inference, testing of
hypotheses, cognitive flexibility, cognitive inhibition
and response to feedback [16]. The number of total
errors and perseverative errors and failure to
maintain a set are the dependent measures. WCST
Figure 1 Trial flow. BWLT, Behavioural Weight Loss Therapy; CRT-O, Cognitive-Remediation Therapy for Obesity.
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reasoning ability to maintain an appropriate
planning and problem-solving strategy across
changing stimulus conditions to achieve a future
goal, and it is the most widely used test of executive
function [35].
2. Digit Span, a subtest of the Wechsler Adult
Intelligence Test III [36]: In this test, the subject is
presented with a series of digits to be repeated in
the same order (Digit Span Forward) followed by
another series to be repeated backwards (Digit Span
Backward). Digit Span Forward assesses the
phonological loop and Digit Span Backward assesses
central executive aspects of the verbal working
memory [37]. The score is calculated based on the
number of correct responses that could be
immediately retained.
3. Trail Making Test (TMT) [38]: This will be used to
assess psychomotor speed, visual integration,
cognitive flexibility and inhibitory control. This test
measures the subject's ability to connect written
numbers in an ascending order (Trail A), and,
afterwards, to connect numbers and letters,
alternating numbers in ascending order and letters
in alphabetical order (Trail B), for example, 1-A-2-B.
The score is the response time taken to complete
the respective trails [35].
4. Computerised Reward–Loss Task [39]: This is a
probabilistic classification task that assesses
decision-making. In each trial, participants view one
of four images and are asked to guess whether it
belongs to category A or B. In the reward-learning
task, if the participant correctly guesses the category
membership for a trial, a reward of +25 points is
received. If the participant guesses incorrectly, no
feedback is given. In the punishment-learning task,
if the participant guesses incorrectly for a trial, a
punishment of −25 points is received, and correct
guesses receive no feedback. The reward and
punishment trials are intermixed so that no-feedback
trials are ambiguous. The ±25 points symbolise
quarter dollars that are won or lost, but no real
payments are used in this study. The dependent
variables are the number of errors made and
completion time.
5. Behaviour Rating Inventory of Executive Function,
Adult Version (BRIEF-A) [40]: This is a widely used,standardised measure based on a multidimensional
model of executive function and the only available
self-report measure of executive function at present.
The BRIEF-A captures information on an adult’s
executive functions or self-regulation in his or her
everyday environment.
6. Rey–Osterrieth Complex Figure Test [41,42]: This
test (both copy and a 3-minute recall) will be used
to measure attention to detail (central coherence),
perceptual and organisational skills, and nonverbal
memory. Scores will be calculated for the copy and
3-minute delay portions of the test using the scoring
manual.Pre-morbid IQ
The Australian version of the National Adult Reading
Test, Revised [43,44] is administered to control for pre-
morbid intelligence. This is a widely used reading test that
provides an estimate of pre-morbid IQ. It consists of 50 ir-
regularly spelled words, listed roughly in order of diffi-
culty. The test involves participants being presented with
a word card and instructed to read each word out aloud.
Interviewers then record correct pronunciations, with the
total number of correct responses being the score.Anthropometric measures
For participants, we measure: (1) height and weight with
calibrated scales (from which we will derive BMI in
kg/m2), and (2) hip and waist circumferences to calcu-
late the waist to hip ratio.Demographics and medical history
Age, gender, education and socio-economic status
(by postcode) are recorded in the general questionnaire.
This form also includes medical history, current medical
conditions and medication.Nutrition and lifestyle behaviours
These are assessed using a written 24-hour dietary recall
method [45]. A brief questionnaire examining basic food
group frequencies and portion sizes, and a questionnaire
on frequency and intensity of exercise are used, both
adapted from large Australian population questionnaires
in the Australian Women’s Health project [46] and the
National Nutrition Survey, Australia [47].
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The Clinical Obesity Maintenance Model [48] proposed
by Raman and colleagues argues that psychological vari-
ables, such as habitual cluster behaviours, emotional dys-
regulation and mood, interact with executive functioning
and impact on the overeating and binge eating behaviours
of obese individuals. Hence, the following measures are in-
cluded in this RCT to investigate the broader range of
maintaining mechanisms, including but not limited to ex-
ecutive deficits, and to ensure both groups are equivalent
at baseline in other measures that may impact on weight.Depression, Anxiety and Stress Scales
Depression symptoms in the obese in this study are
measured by the 21-item Depression, Anxiety and Stress
Scales [49]. Obesity has been shown to increase the risk
of developing depression and depression has been found
to be predictive of obesity [50], and there is a dose–re-
sponse gradient in that the association between depression
and obesity was stronger than the association between de-
pression and being overweight [51]. There is ample evi-
dence that depressive disorders are also associated with
deficits in attentional functions, executive control and low-
ered cognitive flexibility [52]; verbal learning and memory
[53] and interpretation biases [54-57]. This test has been
validated in a number of clinical and non-clinical popula-
tions and is psychometrically sound with good reliability
and validity to measure depressive symptoms [49,58].Eating disorder symptoms
Individuals with eating disorder symptoms, such as
binge eating, may have more difficulty losing weight [59]
and hence this will be controlled for in our analyses. Eat-
ing disorder symptoms are measured by the Eating
Disorder Examination Questionnaire [60]. Acceptable
internal consistency and test–retest reliability have been
demonstrated for this questionnaire [61]. It has 36 items
and measures concerns about shape, weight and eating;
restraint and self-reported binge eating. Subscale scores
for shape, weight and eating concerns and restraint
range between 0 and 6. A higher score indicates more
severe eating psychopathology.The Grazing Questionnaire
The Grazing Questionnaire [62] is used to measure the
participants’ food grazing behaviours, i.e., to assess
whether there is a pattern of continual overeating. Grazing
is increasingly recognised as an important eating behav-
iour associated with obesity [62]. This questionnaire has
been validated in a university sample of both genders and
has demonstrated high internal consistency, test–retest re-
liability and convergent validity at initial testing [62].Habit clusters
Habit clusters are measured by the Modified Self-Reported
Habit Index [63]. Research has shown that when cognitive
resources become limited, individuals are inclined to make
heuristic-based choices [64]. This is reflected in obesity-
maintaining dietary habits. Given the habitual nature of
eating and the rapidity with which people make eating de-
cisions [64], the behaviours are likely to be the conse-
quence of automatic responses to contextual food cues,
many of which lead to increased caloric consumption and
poor dietary choices [65,66]. This index has been shown
to be a valid and reliable scale to measure physical activity
habits [67]. For the purposes of this study, this index has
been modified to include other obesity-related behaviours
such as sedentary behaviours, smoking and alcohol
consumption.
Emotion dysregulation
Emotion dysregulation is measured by the Difficulties in
Emotion Regulation Scale (DERS) [68]. Emotion regula-
tion has been described as a continuous, dynamic system
responsive to all emotional experience, consisting of
both autonomic and controlled processes [69,70], per-
haps mediated by executive function [48]. Since it relates
to obesity, problems in attentional and inhibitory control
have been associated with binge eating and eating path-
ology in adults [71]. The DERS is a 36-item self-report
questionnaire that assesses clinically relevant difficulties in
emotion regulation (with a particular emphasis on negative
emotions). There is evidence to support the reliability of
DERS scores. Specifically, DERS scores have been found to
demonstrate good test–retest reliability [72] and the overall
DERS score and subscale scores have been found to have
high internal consistency within both clinical, for example
[68,73], and nonclinical populations, for example [68,74].
Support for the construct and predictive validity of DERS
scores within both clinical and nonclinical populations has
also been found, for example [69].
Health-related quality of life
HRQoL is measured with the 12-item Short Form [75],
which is a widely used quality of life measure with good
construct and criterion validity and with adequate sensi-
tivity to change.
Behavioural weight-loss group intervention
The BWLT in this RCT targets diet and exercise through
behavioural modification techniques over three 90-minute
weekly sessions. In the first session, obesity-related risk
awareness, challenges with perceived barriers and per-
ceived personal control are discussed in depth. Cognitive
challenging techniques are taught and in-session goal
setting practices are conducted. In the second session,
participants receive comprehensive education about
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tices. Problem-solving techniques are taught so that par-
ticipants can effectively deal with difficult situations that
threaten their weight-control efforts. National physical ac-
tivity guidelines are discussed and further training given
on goal setting and goal achievement. In this last session,
attention is given to motivation enhancement and relapse
prevention strategies to help individuals maintain their
weight loss.
Cognitive Remediation Therapy for Obesity
CRT-O is a manualised intervention that consists of
mental exercises aimed at improving cognitive strategies,
thinking skills and information processing through prac-
tice. CRT, in particular, promotes reflection on thinking
styles, develops metacognition and helps to explore and
apply new thinking strategies in everyday life. The pri-
mary function of CRT is to improve the thinking process
rather than the content [76-78]. In the absence of a pub-
lished manual, a CRT-O manual was developed to meet
the needs of the obese participants for the purposes of
this RCT. The intervention is conducted face-to-face
and delivered by the first author (JR), who is a registered
clinical psychologist in Australia. The principles, struc-
ture and main components of the original CRT-AN are
maintained. Some important modifications, however,
have been made to adapt the manual for obesity and
these are described in Smith et al. [25].
Treatment fidelity
The first author (JR) was trained in a workshop on CRT-
AN by the developers of this treatment approach (Kate
Tchanturia and Helen Davies, Institute of Psychiatry,
King’s College London, UK). The third author (ES) piloted
the different versions of manualised CRT-O with three
people. Concomitant interventions outside of the trial set-
ting are neither encouraged nor prohibited during the
intervention phase. To increase transparency and docu-
mentation as well as for quality and treatment fidelity as-
sessment, 10% of the sessions will be audiotaped.
Data collection, management and analysis
Data is collected at baseline, end-of-treatment and the
3-month follow-up by the trial therapist. An independ-
ent assessment, blind to intervention group, will be
made at the 1-year follow-up. Data is entered, cleaned
and coded by a research assistant, blind to group alloca-
tion, and stored at a secure university facility according
to university protocols. An independent statistician will
conduct all preliminary analyses. The Statistical Package
for Social Sciences (SPSS) statistics will be used.
Neuropsychological measures will first be examined in-
dependently and will then be integrated in an executive
function composite following the procedure recommendedby Rosnow and Rosenthal [79,80] and applied by Clark
et al. [81]. The composite score will be generated by
converting each executive function scale across all assess-
ment points to z- scores, and then averaging across the
measures.
Descriptive statistics will be used to present demographic
and clinical data including eating disorder features. Base-
line univariate between-group tests will be used to com-
pare outcome variables and clinical and demographic data
for the groups. Data will be analysed following the
intention-to-treat principle. Linear mixed effects modelling
[82] will be used to test for between-group differences in
the continuous outcome measures, namely the composite
scores of cognitive function, waist circumference and BMI,
and potential confounds (e.g., levels of depression, anxiety,
stress and emotion dysregulation). Generalised estimating
equations [83] with a logit response function, or logistic re-
gression, will be used for dichotomous outcomes, such as
achieving a 5% reduction in body weight. Effect sizes be-
tween and within the two groups will be calculated with
Cohen’s d computed with the pooled standard deviation,
and the odds ratio will be presented where appropriate.
Ethics and dissemination
The study has been approved by the Human Research
Ethics Committee of the University of Western Sydney
(H9787). Written informed consent has been obtained
from each subject after thorough information about the
study was provided. Participants were advised that all
data collected will be de-identified prior to analysis and
stored securely in electronic and paper forms. All identify-
ing information (e.g., signed consent forms) will be kept
separate from other data and will be held in confidence.
Only investigators and authorised research personnel will
have access to the data. The results will be submitted to
peer-reviewed scientific publications, presented at national
and international scientific meetings, presented to rele-
vant community fora and released in lay synopsis form to
media outlets.
Discussion
Obesity is an important global public health issue. Due to
the long-term failure of interventions for obesity, there is a
desperate need to develop novel and innovative approaches
to treatment. In particular, weight-loss maintenance re-
mains a major challenge. Obese individuals are known to
suffer from significant cognitive deficits, especially in ex-
ecutive function. We have identified the possibility that an
intervention such as CRT could improve treatment out-
comes and has the potential to improve current therapy
practices.
The application to CRT for obesity is highly novel.
Executive function deficiencies in the obese are a poten-
tial target and unlike other contributing factors (e.g. diet
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CRT-O, which aims to improve specific deficiencies such
as inflexibility, poor problem-solving and poor attention
to detail (central coherence), could have benefits for the
health of the increasing number of obese individuals in
our community and reduce the economic burden from
obesity and its medical and psychological sequelae. Our
study is designed to compare two groups, a BWLT and
CRT-O group with a BWLT and no-treatment group,
to allow us to draw conclusions about the specific ef-
ficacy of CRT-O following BWLT training compared to
no treatment.
The strengths of our study design include adequate
concealment of randomised group allocation, use of vali-
dated and standardised assessments, and independent
blinded data analysis. A limitation is that follow-up as-
sessments are blinded only at 1 year. However, this is an
important outcome time, since to be clinically meaningful
for longer-term weight-loss maintenance, improvements
in cognition need to be sustained over time. Furthermore,
the Institute of Medicine has defined criteria for assessing
successful weight maintenance as a weight loss of ≥5%
of body weight that is maintained for at least a year [84].
For the purposes of this study, the Institute of Medicine’s
criteria will be used as a standard definition of suc-
cessful weight maintenance at this study's 1-year follow-
up. Another limitation is that therapeutic time with a
therapist is not matched between conditions and par-
ticipants are not blind to condition, i.e., we are not
employing a control–therapy comparison. As obesity
tends to get worse without treatment, at our 1-year
follow-up, we will examine whether individuals’ BMI is
significantly higher in the no-treatment group compared
to the CRT-O group. We will also control for any add-
itional treatment each group received in that time and
whether the change of executive function predicted that
weight loss.
The design of this RCT offers a pathway to address,
for the first time, the integral aspects of executive func-
tion and its impact on obesity, and their interaction with
other maintaining factors such as emotion dysregulation,
depression and habitual cluster behaviours. It is hoped
that the findings of this RCT will provide an important
first step towards an understanding of the potential of
CRT in obesity. Based on the limited success of current
behavioural weight-loss programmes and coupled with
the data on the executive function deficiencies in obes-
ity, it appears likely that improving an individual’s execu-
tive function has the potential to enhance treatment
outcomes for obesity.
Trial status
Recruitment is now complete; therapy and data collec-
tion are in progress.Abbreviations
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